Boric Acid was added because it works by directly disrupting fungal metabolism and biofilm formation, making it especially valuable in resistant or recurrent infections
Eur Neuropsychopharmacol 82:8291
You can read the full article at Tirzepatide, a novel weekly dual GIP/GLP-1 receptor agonist in development for type 2 diabetes (T2D) and obesity treatment, was analyzed for cardiovascular outcomes
Late-breaking Clinical Trials III, ACC 2025 Scientific Session, 2931 March, Chicago, USA.
Whether you are a patient trying to understand your prescription, a researcher comparing drug classes, or someone exploring GLP-1 options for fat loss , the distinction between insulin and incretin mimetics matters more than most people realize